Intervacc is trading 19.68% down at €0.05, with no company-specific announcement identified to explain the October 7, 2026 move.
- Available company coverage showed no recent news.
- Biotechnology stocks weakened on October 6, with reporting describing a broad-sector selloff. This provides sector context but does not establish a direct cause for Intervacc’s decline.